Why is Medicare rationing Alzheimer’s drugs?
By Kenneth E. Thorpe The FDA has recently approved exciting new treatments that can slow the progression of Alzheimer’s disease, a scourge that claims more American lives than breast cancer and prostate cancer combined. One such medicine, Leqembi, reduced early-stage Alzheimer’s patients’ cognitive decline by 27 percent in clinical trials — a breakthrough that offers